MEREO BIOPHARMA GROUP PLC Other Income
MEREO BIOPHARMA GROUP PLC (MREO) reported Other Income of $300.00 thousand for the 12-month period ending 2025-12-31, per its 10-K filed 2026-03-19.
Financial Statements › Income Statement › Other Income
us-gaap:OtherIncome · last filed 2026-03-19
- MEREO BIOPHARMA GROUP PLC other income for the quarter ending 2025-12-31 was $0.00.
- MEREO BIOPHARMA GROUP PLC other income for the quarter ending 2024-12-31 was $0.00.
- MEREO BIOPHARMA GROUP PLC other income for fiscal 2025 was $300.00K.
- MEREO BIOPHARMA GROUP PLC other income for fiscal 2024 was $0.00.
| Period end | Other Income 3 month | Other Income 9 month | Other Income 12 month |
|---|---|---|---|
| 2025-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-19 | $300.00K 10-K · filed 2026-03-19 | |
| 2025-09-30 | $300.00K 10-Q · filed 2025-11-10 | ||
| 2024-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-19 | $0.00 10-K · filed 2026-03-19 | |
| 2024-09-30 | $0.00 10-Q · filed 2025-11-10 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Greenwich LifeSciences, Inc. (GLSI) | United States | $0.267B | -15.02 |
| Sagimet Biosciences Inc. (SGMT) | United States | $0.279B | |
| Akebia Therapeutics, Inc. (AKBA) | United States | $0.255B | -10.35 |
| Upstream Bio, Inc. (UPB) | United States | $0.284B | -2.42 |
| Perspective Therapeutics, Inc. (CATX) | United States | $0.284B | -3.34 |
| Contineum Therapeutics, Inc. (CTNM) | United States | $0.289B | -4.40 |
| Fulcrum Therapeutics, Inc. (FULC) | United States | $0.289B | -3.28 |
| Lyell Immunopharma, Inc. (LYEL) | United States | $0.248B | -1.32 |
| Pyxis Oncology, Inc. (PYXS) | United States | $0.244B | |
| ROCKET PHARMACEUTICALS, INC. (RCKT) | United States | $0.296B | -21.78 |